Drugs Made in America Acquisition Corp. (NASDAQ:DMAAU – Get Free Report) shares fell 0.1% during mid-day trading on Wednesday . The company traded as low as $10.22 and last traded at $10.22. 2,231 shares were traded during trading, a decline of 96% from the average session volume of 60,269 shares. The stock had previously closed at $10.23.
Drugs Made in America Acquisition Price Performance
The stock’s 50 day moving average price is $10.15.
About Drugs Made in America Acquisition
Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.
Featured Stories
- Five stocks we like better than Drugs Made in America Acquisition
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start
- How to Most Effectively Use the MarketBeat Earnings Screener
- AMD’s AI-Powered Stock Price Rally Just Shifted Gears
- 3 Warren Buffett Stocks to Buy Now
- 5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears
Receive News & Ratings for Drugs Made in America Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drugs Made in America Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
